Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
microRNA-142–mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance
Nelomi Anandagoda, … , Jane K. Howard, Graham M. Lord
Nelomi Anandagoda, … , Jane K. Howard, Graham M. Lord
Published February 11, 2019
Citation Information: J Clin Invest. 2019;129(3):1257-1271. https://doi.org/10.1172/JCI124725.
View: Text | PDF
Research Article Autoimmunity Immunology

microRNA-142–mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance

  • Text
  • PDF
Abstract

Tregs play a fundamental role in immune tolerance via control of self-reactive effector T cells (Teffs). This function is dependent on maintenance of a high intracellular cAMP concentration. A number of microRNAs are implicated in the maintenance of Tregs. In this study, we demonstrate that peripheral immune tolerance is critically dependent on posttranscriptional repression of the cAMP-hydrolyzing enzyme phosphodiesterase-3b (Pde3b) by microRNA-142-5p (miR-142-5p). In this manner, miR-142-5p acts as an immunometabolic regulator of intracellular cAMP, controlling Treg suppressive function. Mir142 was associated with a super enhancer bound by the Treg lineage–determining transcription factor forkhead box P3 (FOXP3), and Treg-specific deletion of miR-142 in mice (TregΔ142) resulted in spontaneous, lethal, multisystem autoimmunity, despite preserved numbers of phenotypically normal Tregs. Pharmacological inhibition and genetic ablation of PDE3B prevented autoimmune disease and reversed the impaired suppressive function of Tregs in TregΔ142 animals. These findings reveal a critical molecular switch, specifying Treg function through the modulation of a highly conserved, cell-intrinsic metabolic pathway. Modulation of this pathway has direct relevance to the pathogenesis and treatment of autoimmunity and cancer.

Authors

Nelomi Anandagoda, Joanna C.D. Willis, Arnulf Hertweck, Luke B. Roberts, Ian Jackson, M. Refik Gökmen, Richard G. Jenner, Jane K. Howard, Graham M. Lord

×

Figure 4

The cell-intrinsic Treg suppressive defect is directly attributable to cell-specific loss of miR-142 expression.

Options: View larger image (or click on image) Download as PowerPoint
The cell-intrinsic Treg suppressive defect is directly attributable to c...
(A) Weight charts of WT, TregΔ142, and Foxp3YFP–Cre × Mir142fl/+ mice (male and female; n > 9). WT and TregΔ142 data are also shown in Figure 3A. (B) Coculture suppression assays (data combined from 3 independent experiments). P values represent comparison between WT, TregΔ142, Foxp3YFP–Cre/WT × Mir142fl/fl, and Foxp3YFP–Cre × Mir142fl/+. **P < 0.01; ***P < 0.001, 1-way ANOVA. n > 4 per group. No significant difference noted between WT and Foxp3YFP–Cre × Mir142fl/+. (C) H&E staining of formalin-fixed, paraffin-embedded sections from ear skin, liver, and lung from FoxP3YFP–Cre/WT × Mir142fl/fl and Foxp3YFP–Cre × Mir142fl/+ mice. Original magnification, ×10. (D) Comparison of spleen weights and cell counts. *P < 0.05; **P < 0.01, 1-way ANOVA. n > 6. (E) YFP+ Tregs as a percentage of the total Treg pool (CD4+CD25+FoxP3+) from WT, TregΔ142, Foxp3YFP–Cre/WT × Mir142fl/fl (female), and Foxp3YFP–Cre × Mir142fl/+ (male and female) mice. n = 4 per group. ***P < 0.001, 1-way ANOVA. (F) Weights of WT, TregΔ142, and Foxp3YFP–Cre/WT × Mir142fl/fl (female). n > 6 per group. One-way ANOVA. (G) Cytokine secretion profiles of CD3+CD4+ and CD3+CD8+ T cells from WT, TregΔ142, Foxp3YFP–Cre/WT × Mir142fl/fl (female), and Foxp3YFP–Cre × Mir142fl/+ mice (male and female). n ≥ 3. **P < 0.01; ***P < 0.001, 1-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts